Cas no 1309589-79-4 (Potentillanoside A)
Potentillanoside A Chemical and Physical Properties
Names and Identifiers
-
- 2alpha,19alpha-dihydroxy-3-oxo-12-ursen-28-oic acid beta-D-glucopyranosyl ester
- 2alpha,19alpha-dihydroxy-3-oxours-12-en-28-oic acid 28-O-beta-D-glucopyranosyl ester
- potentillanoside A
- [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,2R,4aS,6aR,6aS,6bR,8aR,11S,12aR,14bS)-1,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-2H-picene-4a-carboxylate
- 1309589-79-4
- E80685
- DA-77013
- Potentillanoside A
-
- Inchi: 1S/C36H56O10/c1-18-10-13-36(30(43)46-29-26(41)25(40)24(39)21(17-37)45-29)15-14-33(5)19(27(36)35(18,7)44)8-9-23-32(4)16-20(38)28(42)31(2,3)22(32)11-12-34(23,33)6/h8,18,20-27,29,37-41,44H,9-17H2,1-7H3/t18-,20+,21-,22+,23-,24-,25+,26-,27-,29+,32+,33-,34-,35-,36+/m1/s1
- InChI Key: PTHJWWHWYWHNNN-ZLVZUGONSA-N
- SMILES: O[C@]1(C)[C@H](C)CC[C@]2(C(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](C(C(C)(C)[C@@H]5CC[C@]43C)=O)O)[C@@H]21
Computed Properties
- Exact Mass: 648.38734798g/mol
- Monoisotopic Mass: 648.38734798g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 6
- Hydrogen Bond Acceptor Count: 10
- Heavy Atom Count: 46
- Rotatable Bond Count: 4
- Complexity: 1300
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 15
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.3
- Topological Polar Surface Area: 174?2
Potentillanoside A Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| MedChemExpress | HY-N11563-1mg |
Potentillanoside A |
1309589-79-4 | 1mg |
¥3100 | 2024-07-20 | ||
| MedChemExpress | HY-N11563-5mg |
Potentillanoside A |
1309589-79-4 | 5mg |
¥9350 | 2024-07-20 |
Potentillanoside A Related Literature
-
Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
-
Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
-
Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
-
Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
-
Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
Additional information on Potentillanoside A
Exploring Potentillanoside A (CAS No. 1309589-79-4): A Natural Compound with Promising Bioactive Potential
In the realm of natural product chemistry, Potentillanoside A (CAS No. 1309589-79-4) has emerged as a compound of significant interest due to its unique structural properties and potential therapeutic applications. Derived from the genus Potentilla, a group of plants traditionally used in herbal medicine, this glycoside has garnered attention for its bioactive properties. Researchers are increasingly focusing on its role in anti-inflammatory, antioxidant, and neuroprotective activities, aligning with the growing consumer demand for natural alternatives to synthetic pharmaceuticals.
The molecular structure of Potentillanoside A features a sugar moiety attached to a flavonoid-like aglycone, a configuration that enhances its solubility and bioavailability. This structural characteristic is pivotal for its interaction with biological targets, making it a subject of study in drug discovery and nutraceutical development. Recent studies suggest its potential in modulating oxidative stress pathways, a key factor in aging and chronic diseases—a topic frequently searched by users interested in longevity and holistic health.
One of the most compelling aspects of Potentillanoside A is its synergy with other phytochemicals, a phenomenon known as the "entourage effect." This aligns with the rising popularity of plant-based medicine and functional foods, as consumers seek integrative approaches to wellness. For instance, its potential to enhance the efficacy of other antioxidants like quercetin or resveratrol has sparked interest in formulations targeting metabolic health and immune support.
From an industrial perspective, the extraction and standardization of Potentillanoside A present challenges due to its low natural abundance. Advanced techniques such as high-performance liquid chromatography (HPLC) and supercritical fluid extraction are being explored to optimize yield and purity. These methods are frequently queried by professionals in the phytochemistry and natural product manufacturing sectors, reflecting the compound's commercial viability.
Environmental sustainability is another hotspot tied to Potentillanoside A. As the demand for ethically sourced botanicals grows, researchers are investigating cultivation practices and green extraction technologies to minimize ecological impact. This resonates with the eco-conscious consumer base, which often searches for terms like "sustainable bioactive compounds" or "climate-friendly nutraceuticals."
In conclusion, Potentillanoside A (CAS No. 1309589-79-4) represents a fascinating intersection of traditional knowledge and modern science. Its multifaceted applications—from dietary supplements to cosmeceuticals—cater to evolving market trends, while its study addresses critical questions in natural product research. As scientific validation progresses, this compound may well become a cornerstone in the next generation of bioactive ingredients.
1309589-79-4 (Potentillanoside A) Related Products
- 175667-77-3(metaplexigenin 3-O-beta-D-glucopyranosyl-(1->4)-b-(6-deoxy-3-O-methyl)-D-allopyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-cymaropyranose)
- 1002337-06-5(28-O-(beta-D-glucopyranosyl)-3-O-[beta-D-glucopyranosyl-(1->4)-beta-D-xylopyranosyl]-2-oxophytolaccagenic acid)
- 123099-12-7((20R)-3beta-16alpha,20,25-Tetrahydroxy-2beta-(beta-D-tetraacetylglucopyranosyloxy)-10alpha-cucurbit-5-en-22-on)
- 1379657-72-3(metaplexigenin 3-O-beta-D-glucopyranosyl-(1->4)-beta-D-thevetopyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-*beta;-D-cymaropyranosyl-(1->4)-beta-D-cymaropyranose)
- 1309589-77-2(2-oxo-3beta,19alpha-dihydroxy-olean-12-en-28-oic acid beta-D-glucopyranosyl ester)
- 96163-45-0(2-O-beta-D-glucopyranosido-25-O-acetyl-23,24-dihydrocucurbitacin F)
- 123078-37-5((20R)-3beta,16alpha-Diacetoxy-20-hydroxy-24,25,26,27-tetranor-2beta-(beta-D-tetraacetylglucopyranosyloxy)-10alpha-cucurbit-5-en-11,22-dion)
- 879096-80-7(metaplexigenin 3-O-beta-D-digitalopyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-cymaropyranoside)
- 123078-41-1((20R)-16alpha-Acetoxy-3beta-20,25-trihydroxy-2beta-(beta-D-tetraacetylglucopyranosyloxy)-10alpha-cucurbit-5-en-22-on)
- 77704-34-8(2-O-beta-D-glucopyranosido-25-O-acetyl-23,24-dihydrocucurbitacin F)